Beta Cat Pharmaceuticals, Inc.
Records under this name other than the patents Beta Cat Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Beta Cat Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,238,030 | Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia. Formerly held In force · High confidence | In force | High confidence | |
| US 9,725,473 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,963,475 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses Formerly held In force · From the USPTO record | In force | From the USPTO record |